Paloma Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,700
| Closed | -$927K | – | 1261 |
|
|
2024
Q2 | $927K | Sell |
15,700
-16,213
| -51% | -$1.01M | 0.03% | 540 |
|
|
2024
Q1 | $2.55M | Buy |
+31,913
| New | +$2.44M | 0.13% | 202 |
|
|
2023
Q4 | – | Sell |
-40,437
| Closed | -$2.88M | – | 766 |
|
|
2023
Q3 | $2.82M | Buy |
+40,437
| New | +$2.87M | 0.1% | 172 |
|
|
2023
Q2 | – | Sell |
-16,728
| Closed | -$1.24M | – | 791 |
|
|
2023
Q1 | $1.24M | Buy |
16,728
+16,437
| +5,648% | +$1.38M | 0.04% | 328 |
|
|
2022
Q4 | $27.1K | Sell |
291
-9
| -3% | -$868 | ﹤0.01% | 861 |
|
|
2022
Q3 | $29K | Sell |
300
-7,500
| -96% | -$742K | ﹤0.01% | 916 |
|
|
2022
Q2 | $723K | Sell |
7,800
-2,773
| -26% | -$271K | 0.03% | 526 |
|
|
2022
Q1 | $1.07M | Sell |
10,573
-2,367
| -18% | -$249K | 0.03% | 415 |
|
|
2021
Q4 | $1.33M | Buy |
+12,940
| New | +$1.2M | 0.02% | 579 |
|
|
2021
Q3 | – | Sell |
-60,235
| Closed | -$5.03M | – | 1251 |
|
|
2021
Q2 | $5.03M | Buy |
60,235
+48,458
| +411% | +$3.97M | 0.09% | 199 |
|
|
2021
Q1 | $886K | Buy |
+11,777
| New | +$858K | 0.02% | 768 |
|
|
2020
Q4 | – | Sell |
-319
| Closed | -$19K | – | 1748 |
|
|
2020
Q3 | $19K | Sell |
319
-115,861
| -100% | -$7.21M | ﹤0.01% | 2002 |
|
|
2020
Q2 | $7.55M | Buy |
116,180
+97,747
| +530% | +$6.16M | 0.13% | 163 |
|
|
2020
Q1 | $1.09M | Buy |
18,433
+15,453
| +519% | +$1.03M | 0.06% | 269 |
|
|
2019
Q4 | $221K | Sell |
2,980
-6,088
| -67% | -$427K | ﹤0.01% | 1927 |
|
|
2019
Q3 | $573K | Sell |
9,068
-10,507
| -54% | -$623K | 0.01% | 1069 |
|
|
2019
Q2 | $1.07M | Sell |
19,575
-792,308
| -98% | -$42.7M | 0.02% | 669 |
|
|
2019
Q1 | $43.8M | Buy |
811,883
+797,383
| +5,499% | +$49.2M | 1.06% | 10 |
|
|
2018
Q4 | $950K | Buy |
+14,500
| New | +$1.08M | 0.03% | 475 |
|
|
2018
Q3 | – | Sell |
-13,105
| Closed | -$937K | – | 1613 |
|
|
2018
Q2 | $843K | Sell |
13,105
-14,773
| -53% | -$974K | 0.02% | 778 |
|
|
2018
Q1 | $1.73M | Buy |
27,878
+3,187
| +13% | +$229K | 0.03% | 663 |
|
|
2017
Q4 | $1.79M | Buy |
24,691
+11,897
| +93% | +$865K | 0.02% | 721 |
|
|
2017
Q3 | $1.04M | Sell |
12,794
-221,220
| -95% | -$17.5M | 0.01% | 1152 |
|
|
2017
Q2 | $18.8M | Buy |
234,014
+111,946
| +92% | +$8.84M | 0.22% | 49 |
|
|
2017
Q1 | $9.58M | Buy |
122,068
+103,358
| +552% | +$8.25M | 0.12% | 130 |
|
|
2016
Q4 | $1.48M | Sell |
18,710
-58,742
| -76% | -$4.75M | 0.01% | 890 |
|
|
2016
Q3 | $6.89M | Buy |
77,452
+52,202
| +207% | +$4.93M | 0.09% | 137 |
|
|
2016
Q2 | $2.42M | Buy |
25,250
+3,317
| +15% | +$331K | 0.03% | 608 |
|
|
2016
Q1 | $2.27M | Buy |
21,933
+18,430
| +526% | +$1.79M | 0.04% | 432 |
|
|
2015
Q4 | $342K | Sell |
3,503
-11,657
| -77% | -$1.14M | 0.01% | 1256 |
|
|
2015
Q3 | $1.46M | Sell |
15,160
-35,126
| -70% | -$3.69M | 0.03% | 457 |
|
|
2015
Q2 | $5.27M | Sell |
50,286
-122,993
| -71% | -$12.6M | 0.1% | 188 |
|
|
2015
Q1 | $17.9M | Buy |
173,279
+131,309
| +313% | +$13.3M | 0.51% | 27 |
|
|
2014
Q4 | $4.04M | Sell |
41,970
-17,436
| -29% | -$1.54M | 0.17% | 123 |
|
|
2014
Q3 | $4.73M | Sell |
59,406
-40,279
| -40% | -$3.18M | 0.22% | 100 |
|
|
2014
Q2 | $7.51M | Buy |
+99,685
| New | +$7.53M | 0.31% | 76 |
|
|
2014
Q1 | – | Sell |
-146,152
| Closed | -$10.5M | – | 740 |
|
|
2013
Q4 | $10.5M | Buy |
+146,152
| New | +$9.39M | 0.52% | 29 |
|
|
2013
Q3 | – | Sell |
-51,465
| Closed | -$2.94M | – | 963 |
|
|
2013
Q2 | $2.94M | Buy |
+51,465
| New | +$2.98M | 0.16% | 125 |
|
Other funds holding CVS
Paloma Partners's CVS Position: Q3 2024 in Review
Paloma Partners sold out of CVS Health (CVS) in Q3 2024, closing a stake of 15,700 shares — an estimated $927K sold.
Paloma Partners first reported a position in CVS in Q2 2013 and held it in 38 quarters. The position peaked at $43.8M in Q1 2019. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.
- Paloma Partners reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
- Paloma Partners sold 15,700 CVS Health shares in Q3 2024, an estimated $927K.
- Paloma Partners first reported a position in CVS Health in Q2 2013 and held it in 38 quarters.
- Paloma Partners's CVS Health position peaked at $43.8M in Q1 2019.
- 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.
Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.